We noticed you’re blocking ads

Thanks for visiting CRSToday. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://crstoday.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

Cover Stories | Feb 2022

The First Step to Educating Patients Is Understanding the Technology

Refractive IOL options are expanding rapidly. We now have access to myriad IOL designs that can correct presbyopia and astigmatism independently or together. Patient expectations are on a parallel trajectory. Most patients we see today demand spectacle independence, at least for most tasks. New presbyopia-correcting lens designs can help us make their expectations a reality.

Before we can meet patient demands, however, we must understand how the available IOL technologies work and identify their pros and cons. This exercise will help us to offer new IOL technologies confidently to patients.

Guiding patients through IOL selection requires using language that they can understand easily. It also requires sharing only the information that is most pertinent to their daily lives, listening to patients, and asking them the right questions to determine their unique visual requirements. This process can guard against patient dissatisfaction after surgery.

The articles featured in this issue explore the latest presbyopia-correcting IOL technologies and provide information about their design concepts, advantages, and disadvantages. The contributors to this series share how they use new presbyopia-correcting IOLs in their practices, and some even share which IOL they would choose for themselves if they needed cataract surgery today.

Having so many IOLs at our fingertips presents many advantages, but we would be remiss not to mention the potential pitfalls, including patient selection, inventory management and spatial constraints, and unhappy patients in the postoperative period. These issues are all addressed by our contributors.

It’s easy to get overwhelmed by the availability of so many options. We hope that this series can be a guiding light to educating yourself and your patients on new refractive IOL technologies and to deciding which IOL could bring the greatest benefit to each patient.

Karolinne Maia Rocha, MD, PhD Guest Medical Editor
  • Associate Professor of Ophthalmology and Director, Cornea & Refractive Surgery, Medical University of South Carolina, Storm Eye Institute, Charleston, South Carolina
  • Member, CRST Editorial Advisory Board
  • Financial disclosure: Consultant (Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Dompé, Johnson & Johnson Vision, LaserAce, Oyster Point Pharma)
Advertisement - Issue Continues Below
Publication Ad Publication Ad
End of Advertisement - Issue Continues Below